Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP805782.RAJ97fmBScuLziYxlmqgcvvx4VI8GtSRpT4v6CZkHj6Fc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP805782.RAJ97fmBScuLziYxlmqgcvvx4VI8GtSRpT4v6CZkHj6Fc130_assertion type Assertion NP805782.RAJ97fmBScuLziYxlmqgcvvx4VI8GtSRpT4v6CZkHj6Fc130_head.
- NP805782.RAJ97fmBScuLziYxlmqgcvvx4VI8GtSRpT4v6CZkHj6Fc130_assertion wasGeneratedBy ECO_0000203 NP805782.RAJ97fmBScuLziYxlmqgcvvx4VI8GtSRpT4v6CZkHj6Fc130_provenance.
- NP805782.RAJ97fmBScuLziYxlmqgcvvx4VI8GtSRpT4v6CZkHj6Fc130_assertion wasDerivedFrom befree-2016 NP805782.RAJ97fmBScuLziYxlmqgcvvx4VI8GtSRpT4v6CZkHj6Fc130_provenance.
- NP805782.RAJ97fmBScuLziYxlmqgcvvx4VI8GtSRpT4v6CZkHj6Fc130_assertion SIO_000772 20387067 NP805782.RAJ97fmBScuLziYxlmqgcvvx4VI8GtSRpT4v6CZkHj6Fc130_provenance.
- NP805782.RAJ97fmBScuLziYxlmqgcvvx4VI8GtSRpT4v6CZkHj6Fc130_assertion evidence source_evidence_literature NP805782.RAJ97fmBScuLziYxlmqgcvvx4VI8GtSRpT4v6CZkHj6Fc130_provenance.
- NP805782.RAJ97fmBScuLziYxlmqgcvvx4VI8GtSRpT4v6CZkHj6Fc130_assertion description "[We questioned whether the dual SRC/ABL kinase inhibitor dasatinib can affect AML cells and whether differences can be observed with normal CD34(+) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP805782.RAJ97fmBScuLziYxlmqgcvvx4VI8GtSRpT4v6CZkHj6Fc130_provenance.